Towards personalized prostate cancer screening

The value of the prostate-specific antigen (PSA) in prostate cancer (PCa) screening is controversial. Contradictory results have been reported in the literature as to whether PSA-based screening reduces mortality. Also, some of the studies published are methodologically flawed. However, evidence con...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Filella Xavier
Formato:	article
Lenguaje:	EN ES
Publicado:	De Gruyter 2020
Materias:	prostate-specific antigen (psa) screening prostate cancer phi 4kscore Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/40338db0fb904fad9d9df60386ac12cf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:40338db0fb904fad9d9df60386ac12cf
record_format	dspace
spelling	oai:doaj.org-article:40338db0fb904fad9d9df60386ac12cf2021-12-05T14:10:38ZTowards personalized prostate cancer screening2628-491X10.1515/almed-2019-0027https://doaj.org/article/40338db0fb904fad9d9df60386ac12cf2020-01-01T00:00:00Zhttps://doi.org/10.1515/almed-2019-0027https://doaj.org/toc/2628-491XThe value of the prostate-specific antigen (PSA) in prostate cancer (PCa) screening is controversial. Contradictory results have been reported in the literature as to whether PSA-based screening reduces mortality. Also, some of the studies published are methodologically flawed. However, evidence consistently demonstrates that screening programs results in the identification of patients with indolent prostatic tumors which rate has increased.Filella XavierDe Gruyterarticleprostate-specific antigen (psa)screeningprostate cancerphi4kscoreMedical technologyR855-855.5ENESAdvances in Laboratory Medicine, Vol 1, Iss 1, Pp 1941-53 (2020)
institution	DOAJ
collection	DOAJ
language	EN ES
topic	prostate-specific antigen (psa) screening prostate cancer phi 4kscore Medical technology R855-855.5
spellingShingle	prostate-specific antigen (psa) screening prostate cancer phi 4kscore Medical technology R855-855.5 Filella Xavier Towards personalized prostate cancer screening
description	The value of the prostate-specific antigen (PSA) in prostate cancer (PCa) screening is controversial. Contradictory results have been reported in the literature as to whether PSA-based screening reduces mortality. Also, some of the studies published are methodologically flawed. However, evidence consistently demonstrates that screening programs results in the identification of patients with indolent prostatic tumors which rate has increased.
format	article
author	Filella Xavier
author_facet	Filella Xavier
author_sort	Filella Xavier
title	Towards personalized prostate cancer screening
title_short	Towards personalized prostate cancer screening
title_full	Towards personalized prostate cancer screening
title_fullStr	Towards personalized prostate cancer screening
title_full_unstemmed	Towards personalized prostate cancer screening
title_sort	towards personalized prostate cancer screening
publisher	De Gruyter
publishDate	2020
url	https://doaj.org/article/40338db0fb904fad9d9df60386ac12cf
work_keys_str_mv	AT filellaxavier towardspersonalizedprostatecancerscreening
_version_	1718371895656579072

Towards personalized prostate cancer screening

Ejemplares similares